The research team used breast milk data from real newborns to simulate associated metabolism throughout the baby’s body, including various organs. Professor Thiele noted, "New-born screening programmes are crucial for detecting metabolic diseases early on, enhancing infant survival rates and health outcomes. Our models allow researchers to investigate the metabolism of healthy infants as well as infants suffering from inherited metabolic diseases, including those investigated in newborn screening."
These models accurately predicted metabolic responses to various treatment strategies, showcasing their potential in clinical settings.
This pioneering research, published in Cell Metabolism, opens new avenues for precision medicine and personalized healthcare for infants. By understanding the unique metabolic needs of newborns, these digital baby models promise to improve early diagnosis and treatment of medical conditions, ultimately enhancing infant health outcomes.
MEDICA-tradefair.com; Source: HITS gGmbH – Heidelberg Institute for Theoretical Studies